VisCardia

CompanyUnited States

VisCardia develops one asset, in human trials (VisONE System in heart failure with reduced ejection fraction). Mostly device; based in the United States.

1
Asset
Furthest stage: Human trials; 1
Trial: 0
Signals

Pipeline

1

VisONE System
Implantable synchronized diaphragmatic neurostimulation system to improve hemodynamic cardiac function
Human trials, Device, heart failure with reduced ejection fraction

Full company profiles: pipeline, trials, funding and people.

In the full profile

Trials1
Similar companies6